Novaliq is a pharmaceutical company committed to develop best-in-class ocular therapies.Our unique and versatile water-free technology is poised to transform established treatments. Novaliq is headquartered in Heidelberg, Germany and has an office in Cambridge, MA, USA. EyeSol®, Novaliq’s unique and proprietary water-free technology, opens completely new and intriguing opportunities to cure, relief and prevent diseases in various areas of indications for patients. Since December 2019, Novaliq has a strategic cooperation with Bausch + Lomb. In China, Novaliq has a strategic cooperation with Jiangsu Hengrui Pharmaceuticals since November 2019. In April 2019, Novaliq has founded Betaliq Inc., Tampa, USA in collaboration with BLP Management Group, LLC. Novaliq is a biopharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwide for ophthalmology products. Our team of seasoned industry experts is driven by the single mission:.
Heidelberg, Germany
Founded in 2007
51-100 Employees
Medium-Sized
Working industry
Pharmaceuticals
Type of company
Manufacturer
Ownership structure
Sole Proprietorship
Locations
2 Locations
Number of products
8 Products
Specialised areas
Advertising, Public Relations, and Related Services, Pharmaceutical, Scientific Research and Development Services, Medical and Diagnostic Laboratories, Health Care, Medical laboratories, Biotechnology, Medical research Advertising
Novaliq offers a wide range of products and services
Product
CyclASol - Novaliq
Go to product >
Product
Novatears+Omega-3 - Novaliq
Go to product >
Product
NOV03 - Novaliq
Go to product >
Product
Novatears - Novaliq
Go to product >
Product
Products - Novaliq
Go to product >
Product
Novel Drug Product Creation - Novaliq
Go to product >
Product
EyeSol - Novaliq
Go to product >
Product
Technology - Novaliq
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
Germany
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
A
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Novaliq operates in 2 countries around the world
Get an overview of the locations of Novaliq
Location
Country
State
City
Headquarter
Germany
Baden-Württemberg
Heidelberg
Novaliq Inc.
United States
Massachusetts
Cambridge
Some frequent questions that have been asked about Novaliq
Where is Novaliq located?
The company headquarter of Novaliq is located in Heidelberg, Baden-Württemberg, Germany. Novaliq has subsidiaries in United States
How many employees does Novaliq approximately have?
As of the latest available information Novaliq has around 51-100 employees worldwide.
When was Novaliq founded?
Novaliq was founded in 2007
In which industries does Novaliq mainly work?
The company Novaliq has it's main focus in the industries of Pharmaceuticals
What is the current company status of Novaliq?
Based on the founding year and the amount of employees the company Novaliq seems to be a Medium-Sized at the current state. Note that over time that status can change
Check out some interesting alternative companies to Novaliq
Novai
Reading, United Kingdom
11-50 Employees
2020
Novai is a finalist for the BIO Start-up Stadium Competition, 2021. Novai wins best Newcomer in the Clinical Trial Excellence Award 2020. Novai comes second in the finals for the Shenzhen Innovation & Entrepreneurship International Competition 2020. Expand scope of DARC biologic molecule as a targeted drug delivery vehicle which can overcome biological barriers known to impede drug delivery to eye and brain. By delivering DARC in a clearly outlined full-service model, we can boost efficiency, quickly determine efficacy and save you time and money.
NovalGen
London, United Kingdom
11-50 Employees
2019
NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond. Our mission is to create life-enhancing and curative new treatments for people with cancer. Headquartered in London, UK, NovalGen was formed in 2019. NovalGen is guided by our core set of values. The culture of NovalGen reflects these values and they help guide our decisions. NovalGen’s first pipeline product is a proprietary first in class bispecific T cell engager therapies that can safely harness the immune system to fight a wide range of cancers. We are changing the paradigm of cancer therapy with our immunotherapy technology.
Noyavision Pharmaceutical Group
Tehran, Iran
51-100 Employees
2006
Noyavision is a privately owned pharmaceutical company, established in 2006. Noyavision also focus on developing flexible and strong collaborations with a wide range of partners to strengthen its own capabilities. Noyavision is a privately owned pharmaceutical company, established in 2006, focused on developing, manufacturing and selling pharmaceutical and consumer healthcare products for patients. Noyavision Group provides a suite of pharmaceutical services that help clients transform scientific ideas into new treatments. Headquartered in Tehran, Iran, we are a specialty pharmaceutical company, improving the health of patients across the world through our high quality and affordable medicines and educating our large community of stakeholders about how we can help them for a healthier life. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability, maximizing the value we create for our business and our diverse stakeholders.Our business is generated through products that are either acquired from our partners, co-developed by them, or individually developed by our R&D team. The basic principle in the quality policy of Noyavision is the notion that research and development, production, marketing and sales processes should be based upon internal and international quality standards GMP, GDP, GSP in order to meet customer requirements. Develop and deliver innovative pharmaceutical and nutraceutical product that helps the community to have a healthier life.
Novalis Biotechnology Incubation
Ghent, Belgium
1-10 Employees
2018
Novalis Biotech is an early stage venture capital fund in life sciences. Novalis focuses on capital light business models and platform technology. Novalis Biotech is an early stage venture capital investor in life sciences. Our investment ideas focus on the interaction between bio-informatics and life sciences. We strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of diseases. As an early stage private equity/venture capital fund, we are a dynamic and flexible player not restricting ourselves to specific fields of expertise, but open to discuss any proposition in the field of life-sciences. We welcome innovative concepts in healthcare and aim to support their development already at the state of incorporation. Focus areas are: innovative research and manufacturing tools, bioinformatics, genomics, diagnostics and digital health.
Aquanova GmbH
Sankt Wendel, Germany
1-10 Employees
-
We are a FSSC 22000 (Food Safety) certified B2B manufacturer of liquid colloidal formulations called NovaSOL®, founded in 1995 and headquartered in Darmstadt/Germany close to Frankfurt. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect,will therefore be rejected. Parts of the pages or the complete publication including all offers and information might be extended, changed or partly or completely deleted by the author without separate announcement. The use and payment of all offered services are permitted - if and so far technically possible and reasonable - without specification of any personal data or under specification of anonymized data or an alias. Data Protection is very important for AQUANOVA AG. The recording ends as soon as the respective session is ended. They serve to make the Internet offer as a whole more user-friendly and effective, and therefore more convenient for the user. The provider is Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland.
Healome Therapeutics
Birmingham, United Kingdom
1-10 Employees
2021
Healome Therapeutics is a clinical stage company developing treatments for eye conditions, with a particular interest in ocular surface diseases and injuries.. We aim to create products that can help patients and healthcare care providers to obtain transformative clinical and quality of life outcomes through the safest, simplest, and most scalable approaches possible. Our current products under development are based on a proprietary eye drop technology offering combined drug retention, lubrication and protection at the ocular surface.. While we strive to transform eye care over the longer-term, we are committed to improving the field in the near-term as well. Better healthcare by deploying ‘better medicine’ at scale in a way that enables healthcare providers and people to effectively manage the growing and evolving eye health challenges around the world.